Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
1. Isomorphic Labs raises $600 million to enhance AI drug design. 2. Funding includes investments from Alphabet, Thrive Capital, and GV. 3. Partnerships with Eli Lilly and Novartis may yield $3 billion. 4. Capital will help hire top scientists for further AI development. 5. Nobel Prize recognition enhances Isomorphic's credibility in drug discovery.